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Background: Opt-in consent is usually required for research, but is known to introduce selection bias. This is a
particular problem for large scale epidemiological studies using only pre-collected health data. Most previous
studies have shown that members of the public value opt-in consent and can perceive research without consent as
an invasion of privacy. Past research has suggested that people are generally unaware of research processes and
existing safeguards, and that education may increase the acceptability of research without prior informed consent,
but this recommendation has not been formally evaluated. Our objectives were to determine the range of public
opinion about the use of existing medical data for research and to explore views about consent to a secondary
review of medical records for research. We also investigated the effect of the provision of detailed information
about the potential effect of selection bias on public acceptability of the use of data for research.
Methods: We carried out a systematic review of existing literature on public attitudes to secondary use of existing
health records identified by searching PubMed (1966-present), Embase (1974-present) and reference lists of
identified studies to provide a general overview, followed by a qualitative focus group study with 19 older men
recruited from rural and suburban primary care practices in the UK to explore key issues in detail.
Results: The systematic review identified twenty-seven relevant papers and the findings suggested that males and
older people were more likely to consent to a review of their medical data. Many studies noted participants’ lack of
knowledge about research processes and existing safeguards and this was reflected in the focus groups. Focus group
participants became more accepting of the use of pre-collected medical data without consent after being given
information about selection bias and research processes. All participants were keen to contribute to NHS-related
research but some were concerned about data-sharing for commercial gain and the potential misuse of information.
Conclusions: Increasing public education about research and specific targeted information provision could promote
trust in research processes and safeguards, which in turn could increase the acceptability of research without specific
consent where the need for consent would lead to biased findings and impede research necessary to improve public
health.
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Secondary use of health data is common in epidemio-
logical research and reviews of medical records can be of
great benefit in large-scale public health studies due to
the wealth of pre-collected data available. The British
government plans to make de-identified National Health
Service (NHS) data readily available for re-use by the
private sector, unless patients actively opt out [1]. Cur-
rently in the UK informed consent must be sought from
individuals for any use of their identifiable data, includ-
ing when conducting a secondary review of a medical
record [2]. In exceptional circumstances approval can be
sought to waive informed consent, but in practice this
can be difficult to obtain [3-5].
Researchers are concerned about selection bias (or “con-
sent” or “participation” bias) arising from seeking consent,
where systematic differences arise between those who con-
sent and those who do not. The detrimental effect of se-
lection bias on the validity of data has been shown by a
number of studies [6-10], although not all [11]. As there is
no effect on the patient or their care from this type of sec-
ondary research, some researchers argue that consent for
a review of the patient’s record is unnecessary [4,12-14],
and that similar audit-based reviews of records are rou-
tinely undertaken by clinicians, without requiring separate
informed consent [15,16]. It is claimed that NHS medical
records are a comprehensive resource funded by public
money and therefore should be used to further research
for public benefit [1,13,16,17], and that the cost of
consenting is too high and practical obstacles too great
[18-20]. Researchers often note that many participants
cannot be contacted because their clinician denies access,
or they do not respond, while few potential participants
actively refuse to take part [4,7,8,19].
Although researchers may wish for easier access to
medical records to reduce potential bias and the cost of
the consent process, public opinion may not be so per-
missive. Members of the public hold a wide range of
views about the necessity of consent for a review of their
medical records [21-23]. Some would like to be offered
an opportunity to consent for each use of their data; for
others one-off consent would be acceptable to cover all
future research, and some are happy for such research to
go ahead without informed consent. A number of stud-
ies have suggested that members of the public are more
willing to waive consent when they understand the is-
sues involved in carrying out such studies. Two large-
scale UK surveys concluded that the public has low
awareness of how their medical data are used, and if
they are informed about what research entails they are
generally more positive about it [22,23]. In other studies
where the public were asked about consent for second-
ary uses of medical data, participants were found to be
poorly informed about research processes and existingsafeguards, and education was called for to engage par-
ticipants and increase the acceptability of such research
without consent [24-29]. Engaging the public and in-
creasing awareness about research using medical data
was a key recommendation in a UK report on the use of
personal medical data for public good [30].
This study included a systematic literature review and
focus group study. The literature review provided an
overview of the existing evidence and enabled the find-
ings from the focus group to be set in a broader context.
The focus group study was part of the ongoing CAP
(Cluster randomised triAl of testing for Prostate cancer)
trial, which is evaluating the population effectiveness of
a single prostate specific antigen (PSA) test for prostate
cancer [31]. In the focus groups, we elicited views about
consent for a review of existing medical records in gen-
eral. Participants were provided with information about
research processes and selection bias so that we could
investigate whether an understanding of selection bias
would alter views about the necessity of consent for a
review of medical records.
Methods
Systematic review
We searched for any qualitative, mixed method or sur-
vey design study that mentioned reasons or characteris-
tics behind different consent preferences for secondary
review of pre-collected health data. Medical data could
be held in primary or secondary care, and be electronic
or paper-based. Studies requesting consent to any inter-
vention were not included; studies concerned with con-
sent for use of secondary data only were included. There
were no restrictions on publication date or publication
type in the search. The search terms were applied in
English only, however, non-English language papers were
not excluded. Conference abstracts were included.
Search strategy
Studies were identified by searching electronic databases,
and by reviewing the reference lists of included articles
for any further studies that met the inclusion criteria.
We searched PubMed (including Medline) (1966-16th
January 2012) and Embase (1974-16th January 2012).
We used the following electronic search strategy for
all database searches:
((consent OR authorization OR authorisation) AND bias
[title + abstract only]) OR ((confidentiality OR privacy)
AND (medical record OR health record OR health infor-
mation) [title + abstract only]).
Study selection
The flow diagram in Figure 1 shows the papers retrieved
and excluded at each stage of the systematic review. Ti-
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Figure 1 Flow diagram of included studies.
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was unclear from the title and abstract, were retrieved and
the full text articles were reviewed. Data from papers in-
cluded in the full review were abstracted to a standardised
form. Data included type of study (e.g. survey, focus
group), sample size, participant characteristics including
age, gender and any health condition or status. The main
findings from each paper were summarised. As this review
sought both qualitative and quantitative research, a sum-
mary statistical analysis was not performed.
Focus groups
We used qualitative methods to explore the views and
opinions of members of the public about data from a re-
view of their hospital medical records being extracted
and used for research purposes. The focus group meth-
odology was chosen as this allowed exploration of the
opinions of participants in general before presenting
them with information about selection bias and noting
the ways in which their understanding and opinions
changed in relation to the information provided. Focus
groups are considered especially useful where the issues
under discussion are new to people, allowing exploration
of ideas they may not have considered before [32].
Participants
Focus group participants were men potentially eligible
for the CAP study, aged between 50 and 69 years, but
who were not recruited to the study because of their lo-
cation away from the study areas. Participants for the
focus groups were identified at random from the lists oftwo primary care practices. To increase the generalisability
of focus groups we approached primary care practices lo-
cated within an area of some deprivation (higher
deprivation quintile) and a more affluent area (lower
deprivation quintile), as ranked by the UK Index of Mul-
tiple Deprivation [33]. Patients who were considered to
have terminal illness or who the General Practitioner (GP)
deemed unsuitable to participate in the focus groups for
other reasons, for example learning difficulties, were
excluded.
Methods
The focus group study received research ethics commit-
tee approval from Dorset Research Ethics Committee
(ref: 07/H0201/108). Participants meeting the inclusion
criteria were sent an initial invitation letter outlining the
study and requesting they return a reply slip if they were
interested in receiving further information. Interested
men were sent an information sheet, consent form and
short questionnaire, which asked for information about
their general health using the 12-item Short Form
Health Survey (SF-12) [34], and demographic informa-
tion to allow us to balance the participants in each
group according to age and general health status. Men
indicated whether they had worked for the NHS or had
ever taken part in health research so we could gauge the
extent of their prior knowledge about health research.
A total of 19 participants attended three focus groups,
with between 5 and 9 in each group. The number of
focus groups was limited due to time constraints. All
groups were facilitated by EH, with a note taker and sec-
ond researcher present, and followed the same topic
guide, each lasting approximately 90 minutes. Following
initial questions about the contents of hospital medical
records, intended to relax the participants and initiate
discussion, the men were then asked how they would
react to a letter asking them to take part in a study that
wished to review their hospital records. They were asked
if they would be willing to let a researcher have access to
their records for research purposes. We provided infor-
mation about different methods of consent: opt-in, in-
formed consent and opt-out, or presumed consent, and
asked whether they would approve of their records being
reviewed without prior consent being sought.
In order to ensure that participants understood the
processes and some of the issues faced when undertak-
ing such research, a presentation was then given about
possible selection bias arising from having to obtain in-
formed consent; that is, by obtaining consent, certain
groups of people would be more or less likely to agree to
participate, which might alter the findings. Information
was presented verbally along with text and diagrams,
and was given in general and then in the context of a
real-life scenario. There were opportunities for questions
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bias by monitoring their response, and providing further
clarification if necessary.
The participants were then asked whether the possibil-
ity of selection bias changed their opinion about a re-
view of their records without informed consent. To
conclude, we discussed whether any safeguards could be
put in place that would reduce any individual’s require-
ment or preference for informed consent. Throughout,
participants were requested not to talk about their own
medical conditions or experiences.
Analysis
All focus groups were audio recorded with each partici-
pant’s permission, transcribed verbatim and anonymised.
At least two researchers (EH and JD) undertook iterative
thematic analysis of the transcripts using the method of
constant comparison to generate a list of themes.
Themes were compared within and across focus groups
and participants, and the coding and themes were
discussed until all researchers (EH, JD, RM and ET)
agreed with the final list.
Results
Systematic review
The flow diagram in Figure 1 shows the papers retrieved
and excluded at each stage of the systematic review.
Seventy-eight papers were identified as potentially
relevant from the title and abstract of the 1760 unique
papers found by the literature search. Of these, 68 were
excluded on review of the full article. One potentially
relevant conference abstract was also identified and the
author was contacted for further information but did
not reply; this abstract was excluded as it did not con-
tain enough information to meet the inclusion criteria.
After full review, 15 papers met the review criteria. Hand
search of the reference lists of these 15 papers, and those
papers identified from the reference lists, produced an-
other 12 papers. The resulting 27 papers included three
papers using qualitative methods, 12 surveys and two sys-
tematic reviews of surveys that contained information on
the differences between consenters and non-consenters,
and 10 papers using mixed methods. The characteristics
of the included studies are shown in additional files for
both quantitative aspects (Additional file 1a, studies
reporting response rates; and Additional file 1b, studies
reporting perspectives of respondents) and qualitative as-
pects (Additional file 2).
Of the twenty-seven included studies, nine were
conducted in the USA [28,35-42] with one of these fea-
turing US veterans only [42]. Six studies were carried
out in the UK [11,22,23,43-45], one in Eire [46] and one
in New Zealand [11]. Eight studies originated from
Canada [21,24-27,47-49], with two research projectsbeing reported by two papers each [25,47], and [26,27]. Of
the two review papers, one sought only studies from the
UK [10], while the other included papers from Canada,
UK, USA, Ireland, Japan, Taiwan, and Australia [6].
Characteristics of consenters and non-consenters: survey
results
Of the twelve quantitative surveys looking at differences
between those who consented to a review of their medical
records or not, two reported no significant differences be-
tween consenters and non-consenters [11,50], seven pa-
pers reported that males were more likely to consent than
females [24,36,37,40,41,43,48], four reported older respon-
dents more likely to consent [36,37,40,43], while three
noted that those with less sensitive or stigmatising infor-
mation were more likely to consent [24,37,38]. The un-
employed [24] or those not paying for their healthcare in
the US were more likely to consent [38]. Those in poorer
health [40] and people with cancer were more likely to
consent than the general public [35]. One online survey of
the general public found the reverse: that those younger,
in better health and of white ethnicity were more likely to
consent [39].
The systematic review of seven UK surveys found that
overall those with the symptom under investigation were
most likely to consent and consent rates fell in the over
50 age groups, especially for women [10]; however, an-
other systematic review found no clear patterns across
17 international studies on any of variables age, sex, in-
come, education or health status [6].
Patterns of consent were similar in the quantitative as-
pects of the six mixed methods papers that reported dif-
ferences in consent rates between groups: male gender
[21,22,45], older age [23,45,46], having a less sensitive con-
dition [22], being of non-white ethnicity [22], long term
disability [23] and having breast cancer or sickle cell dis-
ease (versus other conditions such as cystic fibrosis or
colon cancer [28]) were factors associated with being more
likely to consent. Participants rating themselves as having
a greater knowledge of the NHS were more likely to con-
sent in one study [45]. Higher socioeconomic status was
associated with higher consent rates in two studies
[23,45], although another study questioning patients with
various conditions including cancer and diabetes found
those on a lower income more likely to consent [28].
Themes arising from previous qualitative research
Three papers were identified reporting qualitative results
only. There were also ten mixed methods papers that in-
cluded a qualitative aspect. The papers focused on five
major themes. The key findings are listed below:
Eleven of the 13 studies noted the lack of current
knowledge that many participants had about how their
medical data may be used for research and the existing
Approached via primary care 
(n=320 approx; exact number 
excluded by General Practitioner 
unknown)
Returned initial reply slip (n=85)
Consent (n=59)
Allocated to focus group (n=23)
Attended focus group (n=19)
Did not attend focus group (n=4)
Not selected for focus group due 
to time constraints (n=36)
Figure 2 Focus group response figures.
Table 1 Sociodemographic characteristics of focus group
participants (n=19)
n %
Mean age in years (SD) 61 (4.84)
Age range 54-69
Marital status




White British 18 95




Unemployed seeking work 1 5
Unemployed due to illness or disability 2 11
Mean SF-12 score*
Physical health component (score*) (52.06)
Mental health component (score*) (51.32)
SD standard deviation.
*Range from 0 to 100, with scores below 50 indicating poorer than
average health.
Hill et al. BMC Medical Research Methodology 2013, 13:72 Page 5 of 10
http://www.biomedcentral.com/1471-2288/13/72safeguards to protect their data [22,23,25-27,42,44-47,49].
There were widespread calls from both the patients and
researchers for increased public education about research
processes and safeguards.
Participants were reported as recognising the benefit
of research for the population in nine of the studies
[23,25-27,42,44-47]. The time and effort involved in
obtaining consent was often balanced against the public
benefit of the research during discussions.
In ten of the studies, participants wished to be informed
about how their data were being used and by whom
[22,23,25-27,42,44-47]. Information about the user of the
data was seen as more important than the intended use in
determining whether to offer consent in some studies
[22,45], while others noted that the planned use of the
data was an important determinant of whether partici-
pants would consent to its use [26,42,47].
Different consent models were discussed in ten papers
[22,23,25,26,42,44-47,49]. There was no consensus on a
preferred model either within or across studies, although
participants often considered the balance of obtaining
consent against the public benefit incurred by unre-
stricted research. Despite this recognition, many partici-
pants maintained that informed consent should always
be sought, out of respect for the individual.
All 13 studies mentioned areas of concern held by par-
ticipants about data sharing. Data and database security
[22,28,46,49], and whether the data were anonymous was
a concern, with participants being less restrictive when
data were anonymous or unidentifiable [22,26,28]. There
was apprehension in many studies that data would be sold
for commercial profit, and this was generally seen as less
acceptable, commanding a higher requirement for in-
formed consent [21,23,25-27,42,44,45,47]. Release of data
to insurance companies or pharmaceutical companies was
often mentioned as a concern, again leading to a more re-
strictive consent requirement [23,26,27,42,44,45,47].
Focus groups
Figure 2 shows the focus group response figures. Ap-
proximately 320 men were invited (exact number of
men excluded by GP unknown), 85 were sent informa-
tion about the study at their request and 59 consented
to take part. Twenty-three men were scheduled to take
part in a focus group, with four of these failing to attend.
Nineteen men (mean age 61 years) took part in our
focus groups; age, occupational and health status were
balanced across groups (Table 1). The characteristics of
the men who consented to be involved and returned a
questionnaire (n = 58) were very similar to those who
attended the groups.
One participant reported having formerly worked for
the NHS (not in a clinical role). No participants reported
taking part in any health research previously; however,one participant had some knowledge of health research
having sat on a local research ethics committee.
Consent for medical record review
All participants accepted the need for research and
understood that this was an important aspect of the
NHS. A few expressed surprise that this sort of research
was not happening as a matter of course. All would con-
sent to a review of their medical records if asked:
“Definitely if it was going to benefit somebody else
then yeah.” (Participant 2, group 2)
When asked about the use of records without their
prior informed consent, opinions were split equally
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benefit and those who thought it was courtesy that they
were informed:
“I’m saying yes because I think there’s a greater good.”
(Participant 1, group 2)
“I think it’s just etiquette to ask people to do such
things.” (Participant 5, group 3)
Understanding of selection bias
Following presentation of information about selection bias
and discussion of issues surrounding the consent process,
participants could understand the difficulties faced by re-
searchers. They recognised the increased cost and time
that the process took and how a low response rate might
bias the findings:
“Well I’d sympathise with the researcher and I think if
you’re setting yourself up to do research which is going
to be skewed by the nature of consent then let’s try and
avoid the issue of going for consent. Let’s get the best
quality research we can do.” (Participant 1, group 2)
We asked if knowing this changed their opinion on
the use of their medical records without their prior con-
sent. Many were already positive about the use of re-
cords without their prior permission and clarified this,
but for those who were more reluctant in the first in-
stance, their opinion did change. However, when asked,
a few men still preferred informed consent. This was
more to do with an interest or curiosity in the kind of
research that they were contributing to. Although they
would like to be informed, participants were still likely
to consent but felt the need to know details of the
research:
“My own personal opinion, as much as I under-
stand the maths of it, is I would still like to be asked.”
(Participant 8, group 3)
Among those who preferred to be informed about re-
search, opt-out consent was considered to be acceptable,
as it satisfied their curiosity and offered a chance for re-
fusal, with less of an impact on the validity of the results.
Safeguards
We asked if there were any safeguards that could be put
into place that would make the men more likely to
accept the scenario of no prior consent. Common
safeguards suggested were anonymisation and data
encryption:
“I think I’d be happy as long it is stays within the area,
it didn’t find its way into a laptop, and it was all
encrypted.” (Participant 1, group 1)
A minority of participants said there could be no safe-
guards that would make them happy with the no con-
sent scenario:
“I don’t want any safeguards, end of story, so I want
prior consultation.” (Participant 5, group 3)Interestingly, no participants spontaneously mentioned
ethics committees, NHS research governance procedures
or legislation when considering potential safeguards.
Throughout the discussion many questions were asked
about how research was carried out, suggesting that par-
ticipants were unaware of how their data could currently
be used, and needed to be able to trust that their data
were secure:
“How do we know that you just don’t go to the hos-
pital and say “can I have a look at these records” and we
don’t know anything about it?” (Participant 8, group 3)
Potential misuse of information
The fear of data being misused by companies for their
own gain was very apparent in all groups. Concerns were
mainly around insurance companies obtaining health in-
formation which may affect their premiums or cover, or
companies using the information for targeted advertising:
“What I don’t like is any information being passed
on to a third party, for promotion purposes. Say you’ve
got a particular problem then it goes to a drugs sup-
plier or something like that, that I would object to.”
(Participant 4, group 1)
Despite the information collected from medical records
being anonymised, the men had the same concerns over
their personal information being disclosed inappropriately
by the researchers as by commercial companies:
“I think we can forget security because let’s face it, it
isn’t there anymore so if you don’t want it to be given
out then you say so…” (Participant 2, group 2)
Although some men seemed resigned to the fact that
there was a lack of security, they were still willing to
consent and would accept the security risk as part of the
process.
Acceptable & unacceptable types of research
In all groups there was discussion around acceptable
and unacceptable types of research. This dichotomy was
based on who profited from the research, rather than
the study design or ethical aspects. Research undertaken
by the NHS was seen as acceptable and for public good,
whereas pharmaceutical companies who gained finan-
cially from the altruistic sharing of records were seen as
less acceptable:
“If there was a large commercial company… [that] had
free and easy access to people’s medical records I don’t
think that would be right. It would further their research
into the particular drug or treatment, but it’d also fur-
ther their profits that would be wrong. But if it was for
medical research for everybody then that would be dif-
ferent.” (Participant 6, group 3)
“Financial gain comes into it then so why should you
then let them look at your records? They’re going to
gain out of it and you’re not…” (Participant 2, group 2)
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where in the middle, and it was the funder of the re-
search and their financial gain that was considered when
making a judgement about the acceptability of the
research:
“The question would be who are the researchers work-
ing for? Are they researching for medical companies, or
universities who are attached to medical companies and
getting funded [by them]?” (Participant 8, group 3).
There was an apparent dichotomy between acceptable
research, seen as being undertaken for the public good,
and less acceptable research, for commercial gain.
The impact of the provision of information
Men became more accepting of research without specific
individual consent following the provision of informa-
tion about bias and research processes, for example the
time and cost of obtaining consent:
“If you’re putting money into a charity for them to re-
search something, you want that research done, not for
it to be spent on the administration to enable the re-
search to be done.” (Participant 5, group 2)
Where concerns remained in the minority, on the
whole these related to the potential misuse of their per-
sonal data, or a wish to be informed about the use of
their data. Participants questioned how the processes
would work, and their need to trust that the data would
be secure was implicit:
“How would it happen, how would you do it, how
would you keep it secure?” (Participant 3, group 1)
Discussion
The systematic review identified twenty-seven relevant
studies. From the quantitative literature, males and those
who were older seemed more likely to consent to a re-
view of their medical records, although this was not con-
firmed in a meta analysis of 17 international studies [6].
Similar themes arose in the qualitative studies. Partici-
pants recognised the benefit of sharing their records for
research, but the majority wanted to know how their
data were being used. The systematic review found that
participants shared many of the same concerns about
disclosing their health data, although the focus on cer-
tain issues reflected the context of each study. Concerns
over data security, data being used by insurance or
pharmaceutical companies and data being sold for com-
mercial gain were common. The UK government’s plans
to allow commercial access to NHS data [1] may be un-
acceptable to the public unless a benefit for the majority
can be demonstrated. Nearly all the identified studies
noted that participants were ill-informed about current
practices and use of their health data and that educating
the public may increase the acceptability of the use of
data for research. Despite the research being carried outin a number of countries, each with different health care
systems and governing laws, the themes were very simi-
lar, suggesting that there are common issues which need
to be addressed if increasing numbers of members of the
public are to agree to a review of their existing medical
data.
Our focus group research explored men’s views about
consent for a review of medical records in the context of
selection bias and the findings reflected the themes aris-
ing from the systematic review. All the men involved
agreed that they would consent to a review of their re-
cords when asked. However, opinion was split when in-
formed consent was not to be sought for such research.
Some were happy to be able to help the “greater good”,
yet others, while understanding this opinion, felt that it
was only courteous to be informed about the research
and that the data should not be taken without the pa-
tient’s knowledge. This accords with previous research
that has shown a wide range of public opinion regarding
consent to review of medical records [21-23]. Following
discussion about selection bias, participants’ views about
research without consent became more favourable, with
some men changing their opinion and no longer stating
the need for specific informed consent. However a small
minority remained adamant that they always want an
opportunity to consent or at least to have an opt-out
consent option. The increasing acceptance following in-
formation provision seen in the focus groups was in con-
trast to two similar studies (reported in three papers)
that provided information and research scenarios to aid
understanding and found that although individual opin-
ions altered throughout the course of the dialogue, ag-
gregated opinion showed little change [25,42,47]. Focus
on selection bias specifically could perhaps influence the
opinions of the participants to a greater extent than
more general consent scenarios and future research
should investigate whether this is seen in other demo-
graphic groups, and the best way to present this infor-
mation to ensure a wide public understanding.
When safeguards were mentioned by the facilitator,
the participants did not seem to value them as tangible
and asked many questions. There was a lack of know-
ledge about current safeguards and there was no spon-
taneous mention of ethical approval, hospital research
governance procedures or the contractual obligations of
the researchers by the participants. In one group there
were questions about data protection laws, but on the
whole participants failed to recognise these existing safe-
guards. The discussion and questions generated showed
that the participants were interested in this and wanted
a greater understanding of the processes involved. Previ-
ous research has also suggested that the public feel
poorly informed and would like more information about
how research is carried out [22-29]; eleven of the
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review also noted their participants’ lack of knowledge.
There were concerns from these focus group partici-
pants about possible misuses of health information such
as passing on health status information to insurance com-
panies or to target advertising for certain treatments.
Older men in another study also feared that records could
be shared with outside agencies [42], and these concerns
were highlighted in other research [23,51]. In the focus
groups, the dichotomy between acceptable and less ac-
ceptable types of research was based on who profited from
the research, rather than the study design or ethical as-
pects, with NHS research for the benefit of the public seen
as an example of good research and pharmaceutical com-
panies acting to gain financially seen as less acceptable.
Scepticism about research for commercial profit was a
common theme and a number of studies noted that par-
ticipants wanted more restrictions on their data where
commercial profit could be made from their information
[21-23,25-27,29,50]. If altruistic sharing of data resulted in
profits that did not benefit the NHS, participants would
have strong reservations about allowing access to their re-
cords. Public education about current research legislation
and data security measures is needed to allay misconcep-
tions about the use and safety of patient data, and this will
be of paramount importance if the proposed access to data
by private industry is to be acceptable.
Many similar themes have been found in the related
area of secondary use of tissue samples for research. A
review of 30 studies reporting views on consent for re-
search using biological samples [52] found a high level
of willingness to donate leftover samples for research
(83-99 %), with marginally less support for commercial
rather than academic research. Nine of the studies noted
that people would like information on how their samples
were used. A recent review of 18 qualitative research pa-
pers also noted comparable themes to those reported
here [53]. Reasons given for allowing excess tissue to be
used for research were for both individual gain and for
public good, but most patients agreed that tissue should
not be used without the patient’s consent. Trust in re-
search institutions that data would be secure and tissue
not exploited was a common theme, with similar con-
cerns about commercial access to samples as seen in our
research.
This study was the first to obtain qualitative opinions
about medical record review both before and after
provision of detailed information about selection bias
and research processes. By providing information about
the problems of selection bias, we were able to explore
how opinions changed in the context of this knowledge.
We were also able to answer the many questions that
arose, which helped to increase understanding of re-
search amongst our participants. Previous work hasnoted that during interviews about consent for medical
record reviews participants were still formulating their
thoughts and did not have mature opinions [26]. The
focus group format allowed our participants to develop
their opinions in an area that was new to them, gaining
insight from the views of others [32]. Our focus groups
concentrated on the provision of specific consent for
each project, however it is possible that participants may
have found broad consent for a number of similar pro-
jects to be satisfactory. Opt-out consent rather than opt-
in consent may also be acceptable and future research
should explore this further. Women and younger males
were not included in our focus groups, and all partici-
pants described themselves as of white ethnicity, so
these are limitations. The systematic review identified
males and older people as more likely to consent to a re-
view of their medical records and, as is true with all re-
search, those who agree to take part are often those who
are more positive about research. Therefore the opinions
generated by the focus group may be more accepting of
such research without consent than the general popula-
tion. Despite this, our focus groups found that there
were still a number of concerns to be allayed about the
research process and that information provision may be
useful to reduce concerns in all groups, not just in those
who are positive about research in general.
Conclusions
The majority of men in our focus groups were happy for
medical record reviews to go ahead without consent,
and even more so when their understandings of selec-
tion bias and appropriate safeguards were enhanced. In-
creasing public education about research is likely to
benefit research, as a greater understanding of the safe-
guards and legislation that governs research should in-
crease public trust and reduce misconceptions. This
could improve consent rates or, as found here, the ac-
ceptability of research without informed consent for “the
greater good” of the National Health Service.
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